Oral hypericin antiviral: Announced a protocol for a Phase I/II trial

VIMRx Pharmaceuticals Inc. (VMRX), Stamford, Conn.
Product:

Read the full 72 word article

How to gain access

Continue reading with a
two-week free trial.